Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1983 3
1984 6
1985 2
1986 1
1987 3
1988 2
1989 1
1991 1
1993 1
1994 1
1995 2
1996 5
1997 8
1998 2
1999 1
2000 5
2001 1
2002 4
2003 3
2004 10
2005 8
2006 4
2007 3
2008 5
2009 9
2010 10
2011 9
2012 11
2013 4
2014 10
2015 11
2016 13
2017 16
2018 21
2019 19
2020 22
2021 23
2022 18
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WS, Feldman T, Lennard A, Belada D, Illés Á, Tobinai K, Tsukasaki K, Yeh SP, Shustov A, Hüttmann A, Savage KJ, Yuen S, Iyer S, Zinzani PL, Hua Z, Little M, Rao S, Woolery J, Manley T, Trümper L; ECHELON-2 Study Group. Horwitz S, et al. Lancet. 2019 Jan 19;393(10168):229-240. doi: 10.1016/S0140-6736(18)32984-2. Epub 2018 Dec 4. Lancet. 2019. PMID: 30522922 Free PMC article. Clinical Trial.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F, Fowler NH, Feugier P, Bouabdallah R, Tilly H, Palomba ML, Fruchart C, Libby EN, Casasnovas RO, Flinn IW, Haioun C, Maisonneuve H, Ysebaert L, Bartlett NL, Bouabdallah K, Brice P, Ribrag V, Daguindau N, Le Gouill S, Pica GM, Martin Garcia-Sancho A, López-Guillermo A, Larouche JF, Ando K, Gomes da Silva M, André M, Zachée P, Sehn LH, Tobinai K, Cartron G, Liu D, Wang J, Xerri L, Salles GA; RELEVANCE Trial Investigators. Morschhauser F, et al. Among authors: maisonneuve h. N Engl J Med. 2018 Sep 6;379(10):934-947. doi: 10.1056/NEJMoa1805104. N Engl J Med. 2018. PMID: 30184451 Free PMC article. Clinical Trial.
COVID-19 comme source de mauvaises publications.
Maisonneuve H. Maisonneuve H. Rev Rhum Ed Fr. 2022 Dec;89(6):535-537. doi: 10.1016/j.rhum.2022.09.007. Epub 2022 Sep 15. Rev Rhum Ed Fr. 2022. PMID: 36123996 Free PMC article. French. No abstract available.
Videos in otorhinolaryngology.
Simon F, Laccourreye O, Jankowski R, Maisonneuve H. Simon F, et al. Among authors: maisonneuve h. Eur Ann Otorhinolaryngol Head Neck Dis. 2021 Oct;138(5):325-326. doi: 10.1016/j.anorl.2020.12.008. Epub 2020 Dec 30. Eur Ann Otorhinolaryngol Head Neck Dis. 2021. PMID: 33388258 Free article. No abstract available.
The art of citation.
Laccourreye O, Jankowski R, Maisonneuve H. Laccourreye O, et al. Among authors: maisonneuve h. Eur Ann Otorhinolaryngol Head Neck Dis. 2022 Mar;139(2):57-58. doi: 10.1016/j.anorl.2021.02.008. Epub 2021 Feb 26. Eur Ann Otorhinolaryngol Head Neck Dis. 2022. PMID: 33642233 Free article. No abstract available.
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
Le Gouill S, Thieblemont C, Oberic L, Moreau A, Bouabdallah K, Dartigeas C, Damaj G, Gastinne T, Ribrag V, Feugier P, Casasnovas O, Zerazhi H, Haioun C, Maisonneuve H, Houot R, Jardin F, Van Den Neste E, Tournilhac O, Le Dû K, Morschhauser F, Cartron G, Fornecker LM, Canioni D, Callanan M, Béné MC, Salles G, Tilly H, Lamy T, Gressin R, Hermine O; LYSA Group. Le Gouill S, et al. Among authors: maisonneuve h. N Engl J Med. 2017 Sep 28;377(13):1250-1260. doi: 10.1056/NEJMoa1701769. N Engl J Med. 2017. PMID: 28953447 Free article. Clinical Trial.
Plan S!
Laccourreye O, Maisonneuve H. Laccourreye O, et al. Among authors: maisonneuve h. Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Oct;136(5):341-342. doi: 10.1016/j.anorl.2019.04.010. Epub 2019 Apr 26. Eur Ann Otorhinolaryngol Head Neck Dis. 2019. PMID: 31036534 Free article. No abstract available.
Predatory journals in otorhinolaryngology.
Laccourreye O, Maisonneuve H. Laccourreye O, et al. Among authors: maisonneuve h. Eur Ann Otorhinolaryngol Head Neck Dis. 2020 Sep;137(4):249-250. doi: 10.1016/j.anorl.2020.03.001. Epub 2020 Mar 12. Eur Ann Otorhinolaryngol Head Neck Dis. 2020. PMID: 32173277 Free article. No abstract available.
Quelles actions pour lutter contre la désinformation sur les produits de santé ?
Micallef J, Maisonneuve H, Muller S, Molimard M, Bégaud B, Cabut S, Daban M, Drici MD, Gatignol C, Grumblat A, Guaspare-Cartron C, Lasserre B, Mebarki A, Pons C, Prabonnaud F, Raynaud C, Saint-Lary O. Micallef J, et al. Among authors: maisonneuve h. Therapie. 2024 Jan-Feb;79(1):75-86. doi: 10.1016/j.therap.2023.10.004. Epub 2023 Oct 29. Therapie. 2024. PMID: 37985308 French. No abstract available.
267 results